MedTrace Logo

Human Epididymis Protein 4 in Normal Menstruating Women

NCT01337999 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2013-12-17

No results posted yet for this study

Summary

The purpose of this study is to determine if Human Epididymis Protein 4 (HE-4) levels vary during the menstrual cycles in ovulatory women. HE-4 is a sensitive serological marker that is elevated in certain ovarian and endometrial cancers and can aid in the diagnosis of these malignant conditions. In order to optimize the utility of HE4 as a tumor marker in premenopausal women, its expression in the normal menstrual cycle needs to be characterized. We hypothesize that HE-4 levels do not vary in the menstrual cycle.

Conditions

  • Healthy Premenopausal Women

Interventions

OTHER

blood draws

5 blood draws during ovulatory menstrual cycles in premenopausal women

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • Women and Infants Hospital of Rhode Island

    lead OTHER

Principal Investigators

  • Beth Plante, M.D. · Women and Infants Hospital of Rhode Island

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01337999 on ClinicalTrials.gov